1 completed, 1 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Exenatide LAR: new trials by email Literature Review of Exenatide LAR trials Research Report on Exenatide LAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes Exenatide LAR, Dulaglutide - Diabetes Mellitus, Type 2 | Phase 4 | Unknown | University of Guadalajara | 30 | 2017-11-17 | 2020-03-26 |
| Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes placebo, Exenatide LAR - Type 2 Diabetes Mellitus | Phase 2 | Completed | AstraZeneca | 45 | 2005-02-01 | 2015-02-24 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Hyperglycemia (1)
AstraZeneca (1) · University of Guadalajara (1)
Mexico (1) · United States (1)
Lisa Porter, MD (1)